T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$2.81B |
| 2 |
Boeing
BA
|
+$1.68B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.33B |
| 4 |
Amphenol
APH
|
+$1.11B |
| 5 |
CME Group
CME
|
+$902M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$3.65B |
| 2 |
Advanced Micro Devices
AMD
|
+$2.51B |
| 3 |
UnitedHealth
UNH
|
+$2.06B |
| 4 |
Uber
UBER
|
+$1.84B |
| 5 |
Adobe
ADBE
|
+$1.44B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.21% |
| 2 | Healthcare | 12.77% |
| 3 | Consumer Discretionary | 11.71% |
| 4 | Financials | 11.15% |
| 5 | Communication Services | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1326
UroGen Pharma
URGN
$2.39B
| $4.2M | ﹤0.01% |
393,984
+381,145
| +2,969% | +$4.56M |
|
|
ZBIO
1327
Zenas BioPharma
ZBIO
$1.98B
| $4.19M | ﹤0.01% |
511,220
+24,366
| +5% | +$380K |
|
1328
Gentex
GNTX
$4.93B
| $4.16M | ﹤0.01% |
144,713
+6,984
| +5% | +$209K |
|
1329
MGIC Investment
MTG
$6.29B
| $4.15M | ﹤0.01% |
175,151
+13,089
| +8% | +$327K |
|
1330
TFI International
TFII
$12B
| $4.15M | ﹤0.01% |
30,736
+418
| +1% | +$59.5K |
|
1331
James River Group Holdings
JRVR
$199M
| $4.14M | ﹤0.01% |
850,526
+428,636
| +102% | +$2.36M |
|
1332
Universal Display
OLED
$4.23B
| $4.14M | ﹤0.01% |
28,300
+2,564
| +10% | +$457K |
|
1333
Kite Realty
KRG
$5.27B
| $4.13M | ﹤0.01% |
163,594
+16,279
| +11% | +$428K |
|
1334
Dropbox
DBX
$7.31B
| $4.12M | ﹤0.01% |
137,060
-211,450
| -61% | -$5.84M |
|
1335
GATX Corp
GATX
$6.34B
| $4.1M | ﹤0.01% |
26,470
+2,480
| +10% | +$369K |
|
1336
Atour Lifestyle Holdings
ATAT
$4.6B
| $4.1M | ﹤0.01% |
152,485
-722,211
| -83% | -$19.4M |
|
1337
iShares Russell Mid-Cap Growth ETF
IWP
$21.1B
| $4.1M | ﹤0.01% |
32,352
| – | – |
|
|
HCP
1338
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
| $4.09M | ﹤0.01% |
119,491
-44,621
| -27% | -$1.51M |
|
|
ALTR
1339
DELISTED
Altair Engineering Inc
ALTR
| $4.08M | ﹤0.01% |
37,373
+5,949
| +19% | +$614K |
|
1340
U-Haul Holding Co Series N
UHAL.B
$12.7B
| $4.07M | ﹤0.01% |
63,487
+5,078
| +9% | +$334K |
|
1341
Ryder
R
$10.1B
| $4.02M | ﹤0.01% |
25,645
-11,758
| -31% | -$1.84M |
|
1342
SL Green Realty
SLG
$4B
| $4.01M | ﹤0.01% |
59,057
-94,001
| -61% | -$6.95M |
|
1343
Metropolitan Bank Holding Corp
MCB
$1.17B
| $4.01M | ﹤0.01% |
68,639
-2,539
| -4% | -$152K |
|
1344
Diamondrock Hospitality Co
DRH
$2.5B
| $4M | ﹤0.01% |
443,153
+76,262
| +21% | +$696K |
|
1345
Knife River
KNF
$3.74B
| $3.99M | ﹤0.01% |
39,287
+6,022
| +18% | +$588K |
|
1346
United Bankshares
UBSI
$6.66B
| $3.99M | ﹤0.01% |
106,262
+8,525
| +9% | +$336K |
|
1347
iShares Russell Mid-Cap Value ETF
IWS
$16.1B
| $3.97M | ﹤0.01% |
30,708
| – | – |
|
1348
Alamo Group
ALG
$2.01B
| $3.96M | ﹤0.01% |
21,297
-13,591
| -39% | -$2.54M |
|
1349
Home BancShares
HOMB
$6.23B
| $3.95M | ﹤0.01% |
139,624
-255,328
| -65% | -$7.37M |
|
1350
Healthcare Realty
HR
$6.58B
| $3.92M | ﹤0.01% |
231,372
-198,372
| -46% | -$3.49M |
|
Similar funds
T. Rowe Price Associates's Q4 2024 Portfolio in Review
As of Q4 2024, T. Rowe Price Associates held 3,110 positions worth $867B, down 0.13% from $869B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
T. Rowe Price Associates's Q4 2024 filing shows 92 new, 1,805 increased, 946 reduced and 96 closed positions. Its largest new stake was South Bow Corp: 12,337,055 shares worth $291M. The largest sale was Apple, an estimated $3.65B.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q4 2024 buy was South Bow Corp: 12,337,055 shares worth $291M.
- T. Rowe Price Associates added most to Broadcom in Q4 2024, an estimated $2.81B increase.
- T. Rowe Price Associates's biggest Q4 2024 reduction was Apple, cutting an estimated $3.65B.
- T. Rowe Price Associates fully exited Tempus AI in Q4 2024, selling an estimated $292M.
- T. Rowe Price Associates's ten largest holdings make up 35% of its $867B portfolio in Q4 2024.
- T. Rowe Price Associates opened 92 new positions and closed 96 in Q4 2024.
- T. Rowe Price Associates's portfolio value fell 0.13% quarter-over-quarter to $867B.
Based on T. Rowe Price Associates's 13F filing for Q4 2024, filed 14 Feb 2025.